These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16251822)

  • 1. Integration of pharmacotherapy for opioid addiction into HIV primary care for HIV/hepatitis C virus-co-infected patients.
    Kresina TF; Eldred L; Bruce RD; Francis H
    AIDS; 2005 Oct; 19 Suppl 3():S221-6. PubMed ID: 16251822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.
    Weiss L; Netherland J; Egan JE; Flanigan TP; Fiellin DA; Finkelstein R; Altice FL;
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S68-75. PubMed ID: 21317597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
    Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for integrating buprenorphine therapy into the primary HIV care setting.
    Basu S; Smith-Rohrberg D; Bruce RD; Altice FL
    Clin Infect Dis; 2006 Mar; 42(5):716-21. PubMed ID: 16447120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
    Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G
    J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical management of opioid dependence in HIV primary care settings.
    Lum PJ; Tulsky JP
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):195-204. PubMed ID: 17089480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and HIV primary care: new opportunities for integrated treatment.
    Khalsa J; Vocci F; Altice F; Fiellin D; Miller V
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S169-72. PubMed ID: 17109302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care.
    Cheever LW; Kresina TF; Cajina A; Lubran R
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S3-6. PubMed ID: 21317591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
    Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Mao J; Edwards RR; Samet JH
    Drug Alcohol Depend; 2015 Aug; 153():286-92. PubMed ID: 26048638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
    Carey KJ; Huang W; Linas BP; Tsui JI
    J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.
    Schackman BR; Merrill JO; McCarty D; Levi J; Lubinski C
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S247-53. PubMed ID: 17109311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.
    Bachireddy C; Weisberg DF; Altice FL
    Addiction; 2015 Dec; 110(12):1869-71. PubMed ID: 26464200
    [No Abstract]   [Full Text] [Related]  

  • 14. Buprenorphine: blending practice and research.
    Ling W; Smith D
    J Subst Abuse Treat; 2002 Sep; 23(2):87-92. PubMed ID: 12220606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
    Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
    Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.
    Altice FL; Sullivan LE; Smith-Rohrberg D; Basu S; Stancliff S; Eldred L
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S178-83. PubMed ID: 17109304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy implications of integrating buprenorphine/naloxone treatment and HIV care.
    Finkelstein R; Netherland J; Sylla L; Gourevitch MN; Cajina A; Cheever L;
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S98-S104. PubMed ID: 21317602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV provider endorsement of primary care buprenorphine treatment: a vignette study.
    Kunins HV; Sohler NL; Roose RJ; Cunningham CO
    Fam Med; 2009; 41(10):722-8. PubMed ID: 19882396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.
    Bruce RD; Dvoryak S; Sylla L; Altice FL
    Int J Drug Policy; 2007 Aug; 18(4):326-8. PubMed ID: 17689382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway.
    Lygren OJ; Bjørnestad R; Løberg EM; Bonnier ML; Buljovcic VB; Johansson KA; Fadnes LT;
    Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):58. PubMed ID: 31864396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.